Arch Venture Fund VI LP

Arch Venture Fund VI LP discloses dealings in 8 companies, chiefly Quanterix Corp, Kythera Biopharmaceuticals Inc and Achaogen, Inc. Between 16 October 2012 and 24 November 2020, the trades on record add up to 39 filings.

No open-market sale appears; the market trades are 6 purchases worth €13.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants and 1 option exercise.

Half of the purchases are above €2.0M and half below.

Most recently, on 24 November 2020, the filings show a transaction in Quanterix Corp. The most recent open-market purchase was published on 13 December 2017, 3,237 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.